1. Home
  2. PBA vs IQV Comparison

PBA vs IQV Comparison

Compare PBA & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pembina Pipeline Corp. (Canada)

PBA

Pembina Pipeline Corp. (Canada)

HOLD

Current Price

$48.87

Market Cap

28.5B

Sector

Energy

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$183.35

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBA
IQV
Founded
1997
1982
Country
Canada
United States
Employees
2974
93000
Industry
Oil & Gas Production
Biotechnology: Commercial Physical & Biological Resarch
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.5B
28.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PBA
IQV
Price
$48.87
$183.35
Analyst Decision
Hold
Strong Buy
Analyst Count
1
16
Target Price
$60.00
$227.13
AVG Volume (30 Days)
997.9K
1.5M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
4.58%
N/A
EPS Growth
N/A
4.67
EPS
N/A
1.61
Revenue
N/A
$9,739,000,000.00
Revenue This Year
$3.45
$6.77
Revenue Next Year
$9.15
$5.89
P/E Ratio
$21.43
$116.04
Revenue Growth
N/A
41.60
52 Week Low
$35.45
$151.58
52 Week High
$50.10
$247.05

Technical Indicators

Market Signals
Indicator
PBA
IQV
Relative Strength Index (RSI) 60.73 58.87
Support Level $36.92 $176.99
Resistance Level $50.10 $191.78
Average True Range (ATR) 0.94 7.10
MACD -0.06 1.48
Stochastic Oscillator 69.67 81.16

Price Performance

Historical Comparison
PBA
IQV

About PBA Pembina Pipeline Corp. (Canada)

Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its operations include transmission pipelines, oil and gas gathering, fractionation, storage, and natural gas liquid exports. It also has a joint venture through the Cedar LNG export terminal.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: